The digital health unicorn Hinge Health plans to acquire Medical device manufacturer Enso is expanding its musculoskeletal therapy solutions.
Enso has developed a non-invasive device that has shown in double-blind clinical studies to reduce pain by 56% and provide clinically effective relief to 86% of patients without medication or surgery, the company said. The Enso device works through a patented electrical stimulation treatment that relaxes the muscles and calms the nerves and is controlled via an app on smartphones.
The company’s device is used in over 100 medical centers across the United States including Stanford, Harvard and Cedars-Sinai for the treatment of chronic and acute pain.
The terms of the deal were not disclosed.
Hinge Health provides a digital platform that uses wearable sensors and personalized health coaching to deliver MSK therapy at home. It developed a digital MSK clinic for the treatment of back and joint pain with special programs for different patient needs, from early prevention to acute pain, chronic pain and surgical rehabilitation.
The digital MSK startup recently deposited a “heavily oversubscribed” Series D round of $ 300 million This brought the valuation to $ 3 billion, according to the company. Hinge Health is aiming for a possible IPO in 2022.
According to Crunchbase, the company has raised $ 426 million to date.
The Enso acquisition will add a new MSK pain tool to the company’s digital clinic.
In the past, non-invasive forms of electrical stimulation provided low frequency pulses that provided limited pain relief. In contrast, high frequency pulse devices provide immediate and long-lasting pain relief, but in the past had to be surgically implanted. According to a Hinge Health press release, Enso’s proprietary breakthrough is that it is both high frequency and non-invasive, delivering non-addictive pain relief in seconds.
“The combination of Hinge Health’s digital MSK clinic with Enso’s non-invasive high frequency pulse technology opens up a new world of pain management. Now, Hinge Health members can access the same clinically effective solution that we have recommended to thousands of our own patients, ”said Amitabh Gulati, MD, director of the Chronic Pain Fellowship at Cornell Weill School of Medicine and president of the World Academy of Pain Medicine .
Each year, 50% of adults will seek treatment for persistent MSK pain, with mixed results.
Of the thousands who have used the Hinge Health Enso, nearly 9 in 10 experienced clinically significant pain relief, with each person experiencing an average pain reduction of 56%.
“Enso’s immediate, clinically validated pain relief complements our existing motion sensor technology and our extensive clinical team,” said Jeffrey Krauss, MD, chief medical officer at Hinge Health, in a statement.
According to the company, four in five employers and health insurers have an MSK digital solution partner associated with Hinge Health.
The Hinge Health Enso is particularly well placed to help members avoid elective surgery and unnecessary opioid prescriptions, the company said.
Enso’s portable pain management solution is completely wireless and can be worn anywhere on the body, even while exercising. It has been shown to help members on long-term leave get back to work faster and is already covered for employee compensation claims.
“We have spent nearly a decade developing Enso’s radio frequency pulse technology to provide unprecedented, non-invasive pain relief. It is so exciting to work with Hinge Health to advance our original mission of bringing this technology to the millions of people in need, ”said Shaun Rahimi, Founder and CEO of Enso.
The MSK attracts new players and investments in the field of digital health. Sword Health recently closed a $ 25 million financing round and Kaia Health closed a $ 26 million financing round in June.
DarioHealth, a digital chronic disease management company, said it would be up this month. expand into the market Acquisition of Upright Technologies for $ 31 million. Meanwhile, in May 2020, Omada Health also moved into virtual MSK care from. invested Adding the virtual physical therapy company Physera to its platform in a reported $ 30 million deal.